Panacea Biotec Limited has informed the Exchange regarding Change in Director(s) of the company.

PANACEABIO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+8.3%1-day move

₹297.40

prior close

₹318.90

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.2+0.1+2.5+1.9+8.3+8.3+7.6+11.9+8.6+11.8+24.7+25.8+33.9+82.6

Up moveDown movePending

AI summary

Panacea Biotec Limited has announced that Mr. Mukul Gupta has completed his second and final term of 5 consecutive years as an Independent Director of the company. His tenure ended on March 31, 2026. As a result, he has ceased to be an Independent Director and also stepped down from all Committee Chairmanship/Membership positions on the Board. The Board expressed appreciation for his guidance and contribution to the company's business growth during his tenure.

Likely market impact

This is a routine governance change as Mr. Gupta completed his fixed term as Independent Director. No immediate impact on operations expected, but the company will need to appoint a new Independent Director to maintain board composition requirements.